TORONTO – October 27, 2021 – Laurentis Energy Partners, an innovator and leader in the clean-energy industry, has joined the Canadian Nuclear Isotope Council (CNIC). Laurentis Energy Partners offers expertise in nuclear, hydro, and solar generation, inspections and engineering, nuclear transportation, materials recycling, and medical isotopes. Following the closure of the National Research Universal (NRU) … Read more
October 26, 2021: On Oct. 21, a historic Private Member’s Bill was introduced into the Legislature by Bill Walker, MPP for Bruce-Grey-Owen Sound. The bill asserted Ontario’s global role as a leader in the supply of medical isotopes to fight COVID, keep hospitals safe, and fight cancer. The motion asks government to: “Recognize the supply … Read more
SASKATOON – Iotron Medical Inc. (Iotron) and Canadian Isotope Innovations Corp. (CIIC) are pleased to announce a collaboration to produce the radioisotope copper-67 (Cu-67) for new cancer therapies. This investment will increase the production capacity of the CIIC-operated facilities in Saskatoon, making Cu-67 more widely available to international cancer researchers. Iotron Medical, a spin-out business … Read more
TORONTO – August 24, 2021 – Niagara Energy Products (NEP), a leader in the field of manufacturing radiation shielded containment vessels for isotopes and nuclear contaminated waste, has joined the Canadian Nuclear Isotope Council (CNIC). NEP has a long and storied history in Canada, with three large manufacturing plants in Ontario, providing high-quality jobs in … Read more
Women in Nuclear (WiN) Canada, an association that has been working to support the objectives of WiN Global by emphasizing and supporting the role that women can and do have in addressing public concerns about nuclear energy and the application of radiation and nuclear technology has signed a partnership with the Canadian Nuclear Isotope Council … Read more
McMaster University and Promation have signed a Memorandum of Understanding (MoU) to work together to bring a new medical isotope technology developed at McMaster to the marketplace. At the center of this collaboration is a new technology for producing lutetium-177 (Lu-177), an increasingly sought-after medical isotope. Clinical trials have shown that Lu-177-based drugs have tremendous … Read more
TORONTO – May 12 , 2021 –The Canadian Nuclear Isotope Council (CNIC) and the Local Organizing Committee of the 11th International Conference on Isotopes (11ICI) have entered into a Memorandum of Understanding to co-promote and support the conference’s success in 2022. The 11ICI will be hosted by Sylvia Fedoruk Canadian Centre for Nuclear Innovation in … Read more
(Ottawa, Ontario – May 10, 2021) – BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass Microspheres for Boston Scientific, a leading global medical device company. Developed for the treatment of patients with hepatocellular carcinoma (HCC), TheraSphere treatment is comprised of millions … Read more
Medical isotope ecosystem directory details tremendous capabilities of Canada’s isotope industry. Today, the Organization of Canadian Nuclear Industries (OCNI) and the Canadian Nuclear Isotope Council (CNIC) released the Canadian Medical Isotope Ecosystem Directory. The directory demonstrates the capabilities of the Canadian isotope sector companies and their leading international expertise as well as highlights the … Read more
On the CNIC’s 3rd birthday we highlight why the isotope sector is key contributor to economic recovery. The importance of nuclear medicine and medical isotopes in our daily lives — and Canada’s global leadership position in this sector — admittedly flies under the radar for most people, and their significance has never been more vital … Read more